Nanomedicine

Nanomedicine is published by Future Medicine Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Nanoparticle-Based Drug Delivery, Nanoplatforms for cancer theranostics and RNA Interference and Gene Delivery, together about 43.1% of its articles. Its main subfields are Biomedical Engineering. (generated from OpenAlex topic counts and CAS ranking data)

Medicine has developed throughout time but has remained forever concerned with the maintenance of health and thus the science of prevention and alleviation, and ultimately curing, of disease. To continue its development in new directions, medicine is now looking to nanomedicine, an emerging scientific specialty born from nanotechnology, which has grown up in the fields of engineering, physics, chemistry and biotechnology, and is now moving into medicine, with huge potential for expansion and development over the next decade and beyond. As our knowledge of the human body continues to improve, nanotechnology will be developed to monitor, repair and control human biological systems at the molecular level. This will offer unique opportunities for developing new therapeutic approaches to diagnose, prevent, treat and eradicate life-threatening diseases and conditions (such as cancer and diabetes), as well as resolving pain and improving medical techniques (such as bone repair and surgical techniques), through various novel nanotechnological approaches. Nanomedicine (ISSN 1743-5889) is a uniquely medicine-focused journal, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics, delivering this essential information in concise, clear and attractive article formats. The journal is a valuable information source for all players in the field – academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community. The nanomedicine field is still in its infancy, however, in the next few years there are likely to be further exciting developments across medical science, engineering, chemistry and physics. Diverse researchers working together under the nanomedicine umbrella will produce findings with potential medical uses: preventing, diagnosing and treating human diseases, as well as relieving pain. Nanomedicine will provide a critical overview of these advances as they unfold, helping to shape the future of medicine in this exciting era.

Source: LetPub

Research area (LetPub): Nanoscience & Nanotechnology

CAS Journal Ranking

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

4.51LetPub · 2026-09-13

CiteScore 2026-06

6.5LetPub · 2026-09-13

SJR 2026-06

0.68LetPub · 2026-09-13

SNIP 2026-06

0.59LetPub · 2026-09-13

h-index

93LetPub · 2026-09-13

h-index

160OpenAlex · 2026-10-01

i10-index

2,419OpenAlex · 2026-10-01

2-year mean citedness

4.87OpenAlex · 2026-10-01

Self-citation rate

4.3%LetPub · 2026-09-13

Share of gold OA articles

5.94%LetPub · 2026-09-13

Volume

Articles per year

178LetPub · 2026-09-13

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Other sources

Average review time (community reports)

about 6 monthsLetPub · 2026-09-13

Average acceptance (community reports)

25%LetPub · 2026-09-13

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

No source has fee information yet; check the journal's website.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Publisher

Future Medicine Ltd.

Country or region

ENGLAND

Language

English

Frequency

Monthly

Founded

2006

ISSN

1743-5889

Electronic ISSN

1748-6963

Official links

• Journal homepage ↗LetPub
• Submission system ↗LetPub